Revvity | PKI - Actif À Court Terme





Actif À Court Terme Changement Date
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 7.62M 2026-06
Bio Techne USD 688.05M 50.62M 2026-03
Bio-Rad Laboratories USD 3.02B 78.4M 2026-06
Bruker USD 2.22B 121.4M 2026-06
Celltrion KRW 481.57B 10.97B 2026-03
Charles River Laboratories USD 1.53B 40.3M 2026-06
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Danaher USD 13.38B 554M 2026-06
Dentsply International USD 1.93B 83M 2026-06
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Illumina USD 2.83B 96M 2026-06
Intuitive Surgical USD 12.33B 807.5M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Laboratory Of America USD 3.81B 743.9M 2026-06
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Mesa Laboratories USD 105.63M 8.2M 2025-12
Mettler Toledo International USD 1.35B 15.48M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
OraSure Technologies USD 222.94M 17.84M 2026-06
Organigram Holdings CAD 250.09M 6.46M 2026-03
Ovoca Bio EUR 2.07M 510K 2025-12
Pacific Biosciences Of California USD 338.64M 30.88M 2026-06
Pharma Mar EUR 280.95M 7.5M 2026-06
Qiagen NV USD 1.66B 116.37M 2026-06
Quest Diagnostics USD 2.84B 278M 2026-06
Quidel USD 1.38B 400K 2026-06
Repligen USD 1.2B 39.19M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Sartorius EUR 1.64B 280M 2026-06
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Tilray USD 729.32M 28.18M 2025-09
Waters USD 3.9B 186M 2026-06
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03